Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Nov 24;16(1):477.
doi: 10.1186/s12906-016-1458-5.

Anti-tumor effects of Abnormal Savda Munziq on the transplanted cervical cancer (U27) mouse model

Zuhragul Omarniyaz  1 , Yang Yu  2 , Tao Yang  1 , Lianlian Shan  1 , Weiwei Miao  1 , Renaguli Reyimu  1 , Halmurat Upur  3 , Ainiwaer Aikemu  4
Affiliations

Anti-tumor effects of Abnormal Savda Munziq on the transplanted cervical cancer (U27) mouse model

Zuhragul Omarniyaz et al. BMC Complement Altern Med. .

Abstract

Background: Abnormal Savda Munziq (ASMq), a traditional uyghur medicine, has shown anti-tumour properties in vitro. it was showed that total flavonoids of ASMq could inhibit the proliferation and enhance the antioxidant ability of human cervix cancer HeLa cell. This study attempts to confirm these effects on the transplanted cervical cancer (U27) mouse model in vivo.

Methods: Forty eight Kunming mice were randomly divided in to six groups: normal control group (Control group), U27 tumor model group (Model group), cyclophosphamide administration group (CTX group),low-dose ASMq group (ASMq.L group), medium-dose ASMq group (ASMq.M group), and high-dose ASMq group (ASMq.H group). The five groups except normal control group transplanted with cervical cancer (U27) cells. We observed mice tumor inhibition rate and conducted the histopathological analysisUsing the western blot assay, the expression of TGF-β1 and TNF-α protein in transplanted cervical cancer U27 tumor tissue were detected.

Results: The tumor inhibition rates of CTX group, ASMq.L group, ASMq.M group, and ASMq.H group were 72.21, 31.27, 60.53 and 51.94% respectively, has obvious antitumor effect. ASMq significantly promote the spleen tlymphocyte proliferation of transplanted cervical cancer U27 mice. Invasive growth and diffusion rate in tumor tissue were accelerate in the transplanted cervical cancer U27 model group. Tumor tissue necrosis of tumor cells are smaller in the medium, high dosage group. Compared with the U27 model group, the expression levels of TGF-β1 protein and TNF-α protein expression exhibited statistically significant decreased in the mice tumor tissues in the CTX administration group and the ASMq administration group.

Conclusions: ASMq has some antitumor effects on U27 model mice in vivo, The effects are achieved not only by improving the immune function of U27 model mice, but also by inhibiting the expression levels of TGF-β1 protein while promoting the expression levels of TNF-α protein.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Pathological examination of mice tumor tissues
Fig. 2
Fig. 2
Expression of TGF-β1 and TNF-α in tumor tissues of mice in each group
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Li H, Tan G, Jiang X, Qiao H, Pan S, Jiang H, Kanwar JR, Sun X. Therapeutic effects of matrine on primary and metastatic breast cancer. Am J Chin Med. 2010;38(6):1115–30. doi: 10.1142/S0192415X10008512. - DOI - PubMed
    1. Schoell WM, Janicek MF, Mirhashmi R. Epidemiology and biology of cervical cancer. Semin Surg Oncol. 1999;16:203–11. doi: 10.1002/(SICI)1098-2388(199904/05)16:3<203::AID-SSU2>3.0.CO;2-C. - DOI - PubMed
    1. Yang G, He W, Cai M, Luo F, Kung H, Guan X, Zeng Y, Xie D. Loss/Down-regulation of tumor suppressor in lung cancer 1 expression is associated with tumor progression and is a biomarker of poor prognosis in ovarian carcinoma. Int J Gynecol Cancer. 2011;21(3):486–93. doi: 10.1097/IGC.0b013e31820fa168. - DOI - PubMed
    1. David AR, Zimmerman MZ. Cancer: an old disease, a new disease or something in between? Nat Rev Cancer. 2010;10:728–33. doi: 10.1038/nrc2914. - DOI - PubMed
    1. Upur H, Dubrovin D, Amat N, Liu W, Moore N, Bauer R, et al. Greco-Arab-Uighur medicine. USA: Acupress; 2013.

Substances